Identity
- Trade Name
- Anti-Reticulin IgG 48 Test(L) FDA UDI
- Generic Name
- Multiple Coeliac disease-associated antibody IVD, control FDA UDI
- Model / Reference
- 5748GL FDA UDI
Identifiers
- Catalog Number
- 5748GL FDA UDI
- Primary DI / UDI-DI
- 00813545022983 FDA UDI
- FDA Product Code
- DBL FDA UDI
- GMDN Term
- Multiple Coeliac disease-associated antibody IVD, control FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 866.5660 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Multiple Coeliac disease-associated antibody IVD, control
Anti-Reticulin IgG 48 Test(L) by Scimedx Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Multiple Coeliac disease-associated antibody IVD, control.
- IMMUNO-TROL — THERADIAG SA
- BioPlex 2200 — Bio-Rad Laboratories · Class I
- BioPlex 2200 — Bio-Rad Laboratories · Class I
- BioPlex 2200 — Bio-Rad Laboratories · Class I
- IMMUNO-TROL — THERADIAG SA
- BioPlex 2200 — Bio-Rad Laboratories · Class I
- Anti-Reticulin IgA Antibody(L) Test — Scimedx Corp. · Class II
- Anti-Reticulin IgG Antibody(L) — Scimedx Corp. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Scimedx Corp.
Sources (1)
- FDA UDI 4fac7141-e701-4cbb-a6a0-88c9590e2e13 34 fields · synced May 29, 2026